RecruitingPhase 3NCT04161768
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Comparative Study of Norfloxacin Versus Norfloxacin With Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Sponsor
Tanta University
Enrollment
80 participants
Start Date
Dec 1, 2018
Study Type
INTERVENTIONAL
Summary
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Eligibility
Inclusion Criteria1
- cirrhotic patients with ascites who had previous episodes of SBP.
Exclusion Criteria1
- \. Allergy or contraindication for the used drugs. 2. Recent antibiotics therapy in the previous 2 weeks. 3. Patients with hepatocellular carcinoma or other neoplasia. 4. Pregnant and lactating women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNorfloxacin
Norfloxacin 400 mg daily
DRUGItopride
Itopride 50 mg three times daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04161768